Consensus Rating1
Buy
Highest Price Target1
$48.00
Lowest Price Target1
$2.00
Consensus Price Target1
$24.40

RAPT Therapeutics (NASDAQ:RAPT) Stock, Analyst Ratings, Price Targets, Forecasts

RAPT Therapeutics Inc has a consensus price target of $24.4 based on the ratings of 16 analysts. The high is $48 issued by Capital One on September 21, 2022. The low is $2 issued by UBS on September 9, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, UBS, and Barclays on November 12, 2024, September 9, 2024, and May 10, 2024, respectively. With an average price target of $3.33 between Wells Fargo, UBS, and Barclays, there's an implied 112.31% upside for RAPT Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jul
1
Aug
1
Sep
1
2
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Wells Fargo
UBS
Barclays
Leerink Partners
Berenberg

1calculated from analyst ratings

Analyst Ratings for RAPT Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for RAPT Therapeutics (RAPT) stock?

A

The latest price target for RAPT Therapeutics (NASDAQ:RAPT) was reported by HC Wainwright & Co. on November 25, 2024. The analyst firm set a price target for $0.00 expecting RAPT to fall to within 12 months (a possible -100.00% downside). 20 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for RAPT Therapeutics (RAPT)?

A

The latest analyst rating for RAPT Therapeutics (NASDAQ:RAPT) was provided by HC Wainwright & Co., and RAPT Therapeutics reiterated their neutral rating.

Q

When was the last upgrade for RAPT Therapeutics (RAPT)?

A

There is no last upgrade for RAPT Therapeutics

Q

When was the last downgrade for RAPT Therapeutics (RAPT)?

A

The last downgrade for RAPT Therapeutics Inc happened on November 11, 2024 when JP Morgan changed their price target from N/A to N/A for RAPT Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for RAPT Therapeutics (RAPT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of RAPT Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for RAPT Therapeutics was filed on November 25, 2024 so you should expect the next rating to be made available sometime around November 25, 2025.

Q

Is the Analyst Rating RAPT Therapeutics (RAPT) correct?

A

While ratings are subjective and will change, the latest RAPT Therapeutics (RAPT) rating was a reiterated with a price target of $0.00 to $0.00. The current price RAPT Therapeutics (RAPT) is trading at is $1.75, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch